Although it is known that Mstn inhibits PGC-1α and thus Fndc5 expression by activating p-Smad3 (Dong et al., 2016), the interaction between these two myokines in the pathogenesis of skeletal muscle dysfunction in COPD has not been reported. This evidence concerns the gene PPARGC1A and chronic obstructive pulmonary disease.